With regards to the Phase 2 trial in patients with Relapsed / Refractory AML (Investigator Sponsored Study in Israel) and since there is nothing else Clinical to get excited about at the moment.
As per the last Quarterly , Clinical programs update :
RI-002 Phase 2 trial in patients with Relapsed / Refractory AML (Investigator Sponsored Study in Israel): The Simon 2 stage design study has progressed to the Phase 2 efficacy (expansion) stage. Three patients have completed treatment in the Phase 2 stage. Results will be reported after 9 patients have completed treatment
In the trial design announcement :
Phase 2, Expansion (Efficacy Stage)
- Up to 17 subjects will be enrolled into a Phase 2 expansion efficacy cohort using a 2-stage Simon design.
- Initially, 9 subjects will be enrolled and treated with the recommended dose of FluCloZan regimen determined in Stage 1.
- If no subject responds according to the response criteria outlined in the European Leukemia Net (ELN) guidelines, in the first 9 subjects, the study will be terminated for futility.
- If at least one subject shows a response, 8 more subjects will be enrolled and treated. If three or more of subjects treated in Stage 2 respond, the null hypothesis can be rejected.
Since the Quarterly says 3 patients were recruited , does that mean that the first patient has showed a response and therefore the recruitment continued ?
And since 3 patients have been recruited and Sheba is still continuing the trial , would that mean that the results in those 3 patients have been positive so far to warrant the trial being continued ?
General Comments / Chat, page-8080
-
- There are more pages in this discussion • 3,348 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAC (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.66 |
Change
-0.020(1.19%) |
Mkt cap ! $282.8M |
Open | High | Low | Value | Volume |
$1.67 | $1.67 | $1.61 | $153.5K | 94.75K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 10000 | $1.62 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.67 | 4080 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 10000 | 1.615 |
1 | 613 | 1.610 |
3 | 11750 | 1.605 |
10 | 117991 | 1.600 |
1 | 6329 | 1.580 |
Price($) | Vol. | No. |
---|---|---|
1.670 | 4080 | 1 |
1.680 | 10129 | 3 |
1.690 | 4628 | 1 |
1.700 | 2574 | 2 |
1.720 | 580 | 1 |
Last trade - 16.10pm 09/09/2024 (20 minute delay) ? |
Featured News
RAC (ASX) Chart |